Shopping Cart 0
Cart Subtotal
USD 0

Kyoto University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Kyoto University (Kyoto) is a research university that offers educational services. The university provides multi disciplinary courses to students of Japan including medicine, engineering, law, letters, and science. It offers medical services, and diagnoses and treats various health problems in the fields of psychiatry, dermatology, ophthalmology, internal medicine, otolaryngology, and sports orthopedic medicine. Kyoto conducts research programs on fetal brain development in chimpanzees, cerebral development in chimpanzees, and others. The university operates through faculties, graduate schools, research institutes, and research and educational centers. It operates in China, Indonesia, India, Thailand, Singapore, Malaysia, Peru, Ethiopia, Vietnam, the US, the UK, Zambia, Kenya, and other countries. Kyoto is headquartered in Kyoto, Japan.

Kyoto University-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Kyoto University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Kyoto University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Kyoto University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Kyoto University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Kyoto University, Medical Devices Deals, 2012 to YTD 2018 10

Kyoto University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Kyoto University, Pharmaceuticals & Healthcare, Deal Details 13

Venture Financing 13

Chordia Therapeutics Raises Funds in Series A Financing 13

KinoPharma Raises USD1.3 Million in Financing Round 14

Kyoto University Innovation Capital to Invest in Kyoto drug discovery research institute 15

Stem Cell & Device Laboratory Raises USD1.8 Million in Series A Financing 16

Partnerships 17

Kyoto University and Shionogi Enter into Research Agreement 17

SanBio Enters into Research Agreement with Kyoto University 18

Center for iPS Cell Research and Application, Takeda Pharma and RIKEN Enter into Partnership 19

CiRA, Takeda Pharma and Yokohama City University Enter into Research Agreement 20

Oncolys BioPharma Enters into Research Agreement with Kyoto University 21

Center for iPS Cell Research and Application Enters into Agreement with Takeda Pharma 22

Dainippon Sumitomo Pharma Extends Research Agreement with CiRA and Hitachi 23

CiRA Enters into Co-Development Agreement with Takeda Pharma 24

Shin Nippon Biomedical Labs Enters Into Research Agreement With Center For iPS Cells Research And Application 25

NanoCarrier Extends Research Agreement With Kyoto University 26

Kyoto University and Shionogi Enter into R&D Agreement 27

Licensing Agreements 28

FGH Biotech Enters into Licensing Agreement with Kyoto University and Tokyo University of Agriculture and Technology 28

Kyoto Drug Discovery & Development Enters into Licensing Agreement with Kyoto University 29

Japan Regenerative Medicine Enters into Licensing Agreement with Kyoto University 30

Sigma Life Science Enters Into Licensing Agreement With Kyoto University 31

Equity Offering 32

BlueRock Therapeutics Spins Out from Kyoto University 32

Kyoto University-Key Competitors 33

Kyoto University-Key Employees 34

Kyoto University-Locations And Subsidiaries 35

Head Office 35

Other Locations & Subsidiaries 35

Recent Developments 37

Government and Public Interest 37

Jul 11, 2017: Accessing DNA in the cell's powerhouse to treat disease 37

Jul 11, 2017: Killing cancer in the heat of the moment 38

Jun 05, 2017: Kyoto University and Astellas Inaugurate "Alliance Station" with Aim of Realizing Advanced Medical Treatments 39

Other Significant Developments 40

Aug 21, 2018: Therabiopharma reports 10,000 times higher curcumin concentration in bloodstream clearly demonstrates strong efficacies with/without Oxaliplatin in an animal study for colon cancer 40

Jan 03, 2017: Japan's foremost medical institute purchases multiple HoloMonitor instruments 42

Appendix 43

Methodology 43

About GlobalData 43

Contact Us 43

Disclaimer 43


List Of Figure

List of Figures

Kyoto University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Kyoto University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Kyoto University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Kyoto University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Kyoto University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Kyoto University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Kyoto University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Kyoto University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Kyoto University, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Kyoto University, Pharmaceuticals & Healthcare, Key Facts 2

Kyoto University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Kyoto University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Kyoto University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Kyoto University, Deals By Therapy Area, 2012 to YTD 2018 9

Kyoto University, Medical Devices Deals, 2012 to YTD 2018 10

Kyoto University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Chordia Therapeutics Raises Funds in Series A Financing 13

KinoPharma Raises USD1.3 Million in Financing Round 14

Kyoto University Innovation Capital to Invest in Kyoto drug discovery research institute 15

Stem Cell & Device Laboratory Raises USD1.8 Million in Series A Financing 16

Kyoto University and Shionogi Enter into Research Agreement 17

SanBio Enters into Research Agreement with Kyoto University 18

Center for iPS Cell Research and Application, Takeda Pharma and RIKEN Enter into Partnership 19

CiRA, Takeda Pharma and Yokohama City University Enter into Research Agreement 20

Oncolys BioPharma Enters into Research Agreement with Kyoto University 21

Center for iPS Cell Research and Application Enters into Agreement with Takeda Pharma 22

Dainippon Sumitomo Pharma Extends Research Agreement with CiRA and Hitachi 23

CiRA Enters into Co-Development Agreement with Takeda Pharma 24

Shin Nippon Biomedical Labs Enters Into Research Agreement With Center For iPS Cells Research And Application 25

NanoCarrier Extends Research Agreement With Kyoto University 26

Kyoto University and Shionogi Enter into R&D Agreement 27

FGH Biotech Enters into Licensing Agreement with Kyoto University and Tokyo University of Agriculture and Technology 28

Kyoto Drug Discovery & Development Enters into Licensing Agreement with Kyoto University 29

Japan Regenerative Medicine Enters into Licensing Agreement with Kyoto University 30

Sigma Life Science Enters Into Licensing Agreement With Kyoto University 31

BlueRock Therapeutics Spins Out from Kyoto University 32

Kyoto University, Key Competitors 33

Kyoto University, Key Employees 34

Kyoto University, Other Locations 35

Kyoto University, Subsidiaries 35

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Kyoto University, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.